ICMAB researcher Judith Guasch obtains "la Caixa" Foundation funding to advance in hydrogels for cancer research

Guasch's team's innovative work on hybrid hydrogels, enabling 3D cell cultures for cancer research applications, has been selected by the CaixaImpulse Innovation Programme to facilitate its introduction to the market.
The project, titled "Biohybrid hydrogels as Artificial Tissues against Cancer," led by Judith Guasch has received funding through the CaixaImpulse Innovation program by the "la Caixa Foundation." This funding will enable Guasch and her team to validate and advance an innovative technology that produces biohybrid hydrogels capable of mimicking various types of tissues, both healthy and malignant.
This novel technology shows significant promise in improving cell production systems, contributing to efficiency improvements, and advancing the development of superior preclinical tools for tumour study. The project, currently at Stage 2 of development, will receive financial support to be utilized over a 24-month period through the CaixaImpulse Innovation program. Additionally, the project will benefit from a comprehensive support framework that includes a Training Programme, a Mentoring Programme, and an Expert Advice Program.
The CaixaImpulse Innovation programme supports biomedical innovation by facilitating the successful transfer of scientific knowledge into products, services, devices, and businesses. With a total funding of €3.3 million, this programme has selected 29 innovative biomedical projects from over 300 applications, in order to facilitate the translation of groundbreaking research outcomes into real healthcare solutions.